Codex DNA Inc
Change company Symbol lookup
Select an option...
DNAY Codex DNA Inc
CAC Camden National Corp
RE Everest Re Group Ltd
URRNF Twenty Seven Co Ltd
TWLV Twelve Seas Investment Co II
FLO Flowers Foods Inc
CAJ Canon Inc
WPC WP Carey Inc
PPT Putnam Premier Income Trust
GME GameStop Corp
Go

Company profile

Codex DNA, Inc. is a synthetic biology company. The Company is focused on enabling researchers to build or write synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) that is ready to use in downstream synthetic biology enabled markets. Its synthetic biology solutions include the BioXp 3250 system, BioXp kits, BioXp portal, Benchtop reagent kits and Biofoundry services. Its BioXp system is an end-to-end automated workstation. The Company's BioXp kits contain all the necessary building blocks and reagents, including the Company's Gibson Assembly branded reagents. The BioXp portal is a user-friendly online portal that offers a guided workflow and design tools. Benchtop reagent kits contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system. Its Biofoundry services enable a customer to order and receive any of the BioXp system endpoint-ready products.

Closing Price
$7.30
Day's Change
0.44 (6.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.41
Day's Low
6.85
Volume
(Light)
Volume:
146,791

10-day average volume:
333,273
146,791

Company Profile

Codex DNA, Inc. is a synthetic biology company. The Company is focused on enabling researchers to build or write synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) that is ready to use in downstream synthetic biology enabled markets. Its synthetic biology solutions include the BioXp 3250 system, BioXp kits, BioXp portal, Benchtop reagent kits and Biofoundry services. Its BioXp system is an end-to-end automated workstation. The Company's BioXp kits contain all the necessary building blocks and reagents, including the Company's Gibson Assembly branded reagents. The BioXp portal is a user-friendly online portal that offers a guided workflow and design tools. Benchtop reagent kits contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system. Its Biofoundry services enable a customer to order and receive any of the BioXp system endpoint-ready products.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
--
Price/Book (MRQ)
1.96x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

January 2022
Current Month
2.1M
Previous Month
1.0M
Percent of Float
12.47%
Days to Cover
2.7971 Days

Share Information

DNAY is in a share class of common stock
Float
17.2M
Shares Outstanding
29.3M
Institutions Holding Shares
64
57.56%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

No company officers listed.

Address

  • 9535 Waples Street, Suite 100
  • San Diego, CA 92121-2993
  • Phone: (858) 228-4115
  • Fax: (302) 636-5454
  • https://codexdna.com/

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.